0
     

Report Added
Report already added
Cyclophosphamide Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Cyclophosphamide Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma._x000D_
_x000D_
This report contains market size and forecasts of Cyclophosphamide in India, including the following market information:_x000D_
India Cyclophosphamide Market Revenue, 2015-2020, 2021-2026, ($ millions)_x000D_
India Cyclophosphamide Market Consumption, 2015-2020, 2021-2026, (Person)_x000D_
India Cyclophosphamide Production Capacity, 2015-2020, 2021-2026, (Person)_x000D_
Top Five Competitors in India Cyclophosphamide Market 2019 (%)_x000D_
The global Cyclophosphamide market was valued at 648.4 million in 2019 and is projected to reach US$ 702.9 million by 2026, at a CAGR of 2.0% during the forecast period. While the Cyclophosphamide market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026._x000D_
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cyclophosphamide manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas._x000D_
This report also analyses and evaluates the COVID-19 impact on Cyclophosphamide production and consumption in India_x000D_
Total Market by Segment:_x000D_
India Cyclophosphamide Market, By Type, 2015-2020, 2021-2026 ($ millions) & (Person)_x000D_
India Cyclophosphamide Market Segment Percentages, By Type, 2019 (%)_x000D_
High-Dose_x000D_
Low-Dose_x000D_
_x000D_
India Cyclophosphamide Market, By Application, 2015-2020, 2021-2026 ($ millions) & (Person)_x000D_
India Cyclophosphamide Market Segment Percentages, By Application, 2019 (%)_x000D_
Cancer_x000D_
Autoimmune Diseases_x000D_
AL Amyloidosis_x000D_
Others_x000D_
_x000D_
Competitor Analysis_x000D_
The report also provides analysis of leading market participants including:_x000D_
Total Cyclophosphamide Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)_x000D_
Total Cyclophosphamide Market Competitors Revenues Share in India, by Players 2019 (%)_x000D_
Total India Cyclophosphamide Market Competitors Sales, by Players 2015-2020 (Estimated), (Person)_x000D_
Total India Cyclophosphamide Market Competitors Sales Market Share by Players 2019 ($ millions)_x000D_
Further, the report presents profiles of competitors in the market, including the following:_x000D_
Baxter_x000D_
Novartis_x000D_
Hikma Pharmaceuticals_x000D_
Amneal Pharmaceuticals LLC_x000D_
Jiangsu Hengrui Medicine_x000D_
NorthStar Rx LLC_x000D_
GLS Pharma_x000D_
1 Introduction to Research & Analysis Reports_x000D_
1.1 Cyclophosphamide Market Definition_x000D_
1.2 Market Segments_x000D_
1.2.1 Segment by Type_x000D_
1.2.2 Segment by Application_x000D_
1.3 India Cyclophosphamide Market Overview_x000D_
1.4 Features & Benefits of This Report_x000D_
1.5 Methodology & Sources of Information_x000D_
1.5.1 Research Methodology_x000D_
1.5.2 Research Process_x000D_
1.5.3 Base Year_x000D_
1.5.4 Report Assumptions & Caveats_x000D_
_x000D_
2 COVID-19 Impact: India Cyclophosphamide Overall Market Size_x000D_
2.1 India Cyclophosphamide Market Size: 2020 VS 2026_x000D_
2.2 India Cyclophosphamide Revenue, Prospects & Forecasts: 2015-2026_x000D_
2.3 India Cyclophosphamide Sales (Consumption): 2015-2026_x000D_
_x000D_
3 Company Landscape_x000D_
3.1 Top Cyclophosphamide Players in India (including Foreign and Local Companies)_x000D_
3.2 Top India Cyclophosphamide Companies Ranked by Revenue_x000D_
3.3 India Cyclophosphamide Revenue by Companies (including Foreign and Local Companies)_x000D_
3.4 India Cyclophosphamide Sales by Companies (including Foreign and Local Companies)_x000D_
3.5 India Cyclophosphamide Price by Manufacturer (2015-2020)_x000D_
3.6 Top 3 and Top 5 Cyclophosphamide Companies in India, by Revenue in 2019_x000D_
3.7 India Manufacturers Cyclophosphamide Product Type_x000D_
3.8 Tier 1, Tier 2 and Tier 3 Cyclophosphamide Players in India_x000D_
3.8.1 List of India Tier 1 Cyclophosphamide Companies_x000D_
3.8.2 List of India Tier 2 and Tier 3 Cyclophosphamide Companies_x000D_
_x000D_
4 Sights by Product_x000D_
4.1 Overview_x000D_
4.1.1 By Type - India Cyclophosphamide Market Size Markets, 2020 & 2026_x000D_
4.1.2 High-Dose_x000D_
4.1.3 Low-Dose_x000D_
4.2 By Type - India Cyclophosphamide Revenue & Forecasts_x000D_
4.2.1 By Type - India Cyclophosphamide Revenue, 2015-2020_x000D_
4.2.2 By Type - India Cyclophosphamide Revenue, 2021-2026_x000D_
4.2.3 By Type - India Cyclophosphamide Revenue Market Share, 2015-2026_x000D_
4.3 By Type - India Cyclophosphamide Sales & Forecasts_x000D_
4.3.1 By Type - India Cyclophosphamide Sales, 2015-2020_x000D_
4.3.2 By Type - India Cyclophosphamide Sales, 2021-2026_x000D_
4.3.3 By Type - India Cyclophosphamide Sales Market Share, 2015-2026_x000D_
4.4 By Type - India Cyclophosphamide Price (Manufacturers Selling Prices), 2015-2026_x000D_
5 Sights by Application_x000D_
5.1 Overview_x000D_
5.1.1 By Application - India Cyclophosphamide Market Size, 2020 & 2026_x000D_
5.1.2 Cancer_x000D_
5.1.3 Autoimmune Diseases_x000D_
5.1.4 AL Amyloidosis_x000D_
5.1.5 Others_x000D_
5.2 By Application - India Cyclophosphamide Revenue & Forecasts_x000D_
5.2.1 By Application - India Cyclophosphamide Revenue, 2015-2020_x000D_
5.2.2 By Application - India Cyclophosphamide Revenue, 2021-2026_x000D_
5.2.3 By Application - India Cyclophosphamide Revenue Market Share, 2015-2026_x000D_
5.3 By Application - India Cyclophosphamide Sales & Forecasts_x000D_
5.3.1 By Application - India Cyclophosphamide Sales, 2015-2020_x000D_
5.3.2 By Application - India Cyclophosphamide Sales, 2021-2026_x000D_
5.3.3 By Application - India Cyclophosphamide Sales Market Share, 2015-2026_x000D_
5.4 By Application - India Cyclophosphamide Price (Manufacturers Selling Prices), 2015-2026_x000D_
6 Manufacturers & Brands Profiles_x000D_
6.1 Baxter_x000D_
6.1.1 Baxter Corporate Summary_x000D_
6.1.2 Baxter Business Overview_x000D_
6.1.3 Baxter Cyclophosphamide Major Product Offerings_x000D_
6.1.4 Baxter Sales and Revenue in India (2015-2020)_x000D_
6.1.5 Baxter Key News_x000D_
6.2 Novartis_x000D_
6.2.1 Novartis Corporate Summary_x000D_
6.2.2 Novartis Business Overview_x000D_
6.2.3 Novartis Cyclophosphamide Major Product Offerings_x000D_
6.2.4 Novartis Sales and Revenue in India (2015-2020)_x000D_
6.2.5 Novartis Key News_x000D_
6.3 Hikma Pharmaceuticals_x000D_
6.3.1 Hikma Pharmaceuticals Corporate Summary_x000D_
6.3.2 Hikma Pharmaceuticals Business Overview_x000D_
6.3.3 Hikma Pharmaceuticals Cyclophosphamide Major Product Offerings_x000D_
6.3.4 Hikma Pharmaceuticals Sales and Revenue in India (2015-2020)_x000D_
6.3.5 Hikma Pharmaceuticals Key News_x000D_
6.4 Amneal Pharmaceuticals LLC_x000D_
6.4.1 Amneal Pharmaceuticals LLC Corporate Summary_x000D_
6.4.2 Amneal Pharmaceuticals LLC Business Overview_x000D_
6.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Major Product Offerings_x000D_
6.4.4 Amneal Pharmaceuticals LLC Sales and Revenue in India (2015-2020)_x000D_
6.4.5 Amneal Pharmaceuticals LLC Key News_x000D_
6.5 Jiangsu Hengrui Medicine_x000D_
6.5.1 Jiangsu Hengrui Medicine Corporate Summary_x000D_
6.5.2 Jiangsu Hengrui Medicine Business Overview_x000D_
6.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Major Product Offerings_x000D_
6.5.4 Jiangsu Hengrui Medicine Sales and Revenue in India (2015-2020)_x000D_
6.5.5 Jiangsu Hengrui Medicine Key News_x000D_
6.6 NorthStar Rx LLC_x000D_
6.6.1 NorthStar Rx LLC Corporate Summary_x000D_
6.6.2 NorthStar Rx LLC Business Overview_x000D_
6.6.3 NorthStar Rx LLC Cyclophosphamide Major Product Offerings_x000D_
6.6.4 NorthStar Rx LLC Sales and Revenue in India (2015-2020)_x000D_
6.6.5 NorthStar Rx LLC Key News_x000D_
6.7 GLS Pharma_x000D_
6.6.1 GLS Pharma Corporate Summary_x000D_
6.6.2 GLS Pharma Business Overview_x000D_
6.6.3 GLS Pharma Cyclophosphamide Major Product Offerings_x000D_
6.4.4 GLS Pharma Sales and Revenue in India (2015-2020)_x000D_
6.7.5 GLS Pharma Key News_x000D_
6.8 CSC Pharmaceuticals International_x000D_
6.8.1 CSC Pharmaceuticals International Corporate Summary_x000D_
6.8.2 CSC Pharmaceuticals International Business Overview_x000D_
6.8.3 CSC Pharmaceuticals International Cyclophosphamide Major Product Offerings_x000D_
6.8.4 CSC Pharmaceuticals International Sales and Revenue in India (2015-2020)_x000D_
6.8.5 CSC Pharmaceuticals International Key News_x000D_
_x000D_
7 Cyclophosphamide Production Capacity, Export and Import Analysis_x000D_
7.1 Cyclophosphamide Production Capacity and Value in India, Situation Analysis and Prediction, 2015-2026_x000D_
7.1.1 India Cyclophosphamide Production Capacity, 2015-2026_x000D_
7.1.2 India Cyclophosphamide Production 2015-2026_x000D_
7.1.3 India Cyclophosphamide Production Value 2015-2026_x000D_
7.2 Key Local Cyclophosphamide Manufacturers in India_x000D_
7.2.1 India Key Local Cyclophosphamide Manufacturers Production Capacity_x000D_
7.2.2 India Key Local Cyclophosphamide Manufacturers Production_x000D_
7.2.3 India Key Local Cyclophosphamide Manufacturers Production Value_x000D_
7.2.4 The Proportion of Cyclophosphamide Production Sold in India and Sold Other Than India by Manufacturers_x000D_
7.3 Cyclophosphamide Export and Import in India_x000D_
7.3.1 India Cyclophosphamide Export Market_x000D_
7.3.2 India Cyclophosphamide Source of Imports_x000D_
_x000D_
8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints_x000D_
8.1 PESTLE Analysis for India Cyclophosphamide Market_x000D_
8.2 Market Opportunities & Trends_x000D_
8.3 Market Drivers_x000D_
8.4 Market Restraints_x000D_
_x000D_
9 COVID-19 Impact on Cyclophosphamide Supply Chain Analysis_x000D_
9.1 Supply Chain Analysis_x000D_
9.2 Upstream Market Analysis_x000D_
9.3 Downstream and Clients Market Analysis_x000D_
9.4 Marketing Channels Analysis_x000D_
9.4.1 Marketing Channels_x000D_
9.4.2 Cyclophosphamide Distributors and Sales Agents in India_x000D_
_x000D_
10 Conclusion_x000D_
_x000D_
11 Appendix_x000D_
11.1 Note_x000D_
11.2 Examples of Clients_x000D_
11.3 Disclaimer_x000D_
List of Tables_x000D_
Table 1. Key Players of Cyclophosphamide in India_x000D_
Table 2. Top Players in India, Ranking by Revenue (2019)_x000D_
Table 3. India Cyclophosphamide Revenue by Companies, (US$, Mn), 2015-2020_x000D_
Table 4. India Cyclophosphamide Revenue Share by Companies, 2015-2020_x000D_
Table 5. India Cyclophosphamide Sales by Companies, (Person), 2015-2020_x000D_
Table 6. India Cyclophosphamide Sales Share by Companies, 2015-2020_x000D_
Table 7. Key Manufacturers Cyclophosphamide Price (2015-2020) (Average Cost/Person)_x000D_
Table 8. India Manufacturers Cyclophosphamide Product Type_x000D_
Table 9. List of India Tier 1 Cyclophosphamide Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 10. List of India Tier 2 and Tier 3 Cyclophosphamide Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 11. By Type - Cyclophosphamide Revenue in India (US$, Mn), 2015-2020_x000D_
Table 12. By Type - Cyclophosphamide Revenue in India (US$, Mn), 2021-2026_x000D_
Table 13. By Type - Cyclophosphamide Sales in India (Person), 2015-2020_x000D_
Table 14. By Type - Cyclophosphamide Sales in India (Person), 2021-2026_x000D_
Table 15. By Application - Cyclophosphamide Revenue in India, (US$, Mn), 2015-2020_x000D_
Table 16. By Application - Cyclophosphamide Revenue in India, (US$, Mn), 2021-2026_x000D_
Table 17. By Application - Cyclophosphamide Sales in India, (Person), 2015-2020_x000D_
Table 18. By Application - Cyclophosphamide Sales in India, (Person), 2021-2026_x000D_
Table 19. Baxter Corporate Summary_x000D_
Table 20. Baxter Cyclophosphamide Product Offerings_x000D_
Table 21. Baxter Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)_x000D_
Table 22. Novartis Corporate Summary_x000D_
Table 23. Novartis Cyclophosphamide Product Offerings_x000D_
Table 24. Novartis Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)_x000D_
Table 25. Hikma Pharmaceuticals Corporate Summary_x000D_
Table 26. Hikma Pharmaceuticals Cyclophosphamide Product Offerings_x000D_
Table 27. Hikma Pharmaceuticals Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)_x000D_
Table 28. Amneal Pharmaceuticals LLC Corporate Summary_x000D_
Table 29. Amneal Pharmaceuticals LLC Cyclophosphamide Product Offerings_x000D_
Table 30. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)_x000D_
Table 31. Jiangsu Hengrui Medicine Corporate Summary_x000D_
Table 32. Jiangsu Hengrui Medicine Cyclophosphamide Product Offerings_x000D_
Table 33. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)_x000D_
Table 34. NorthStar Rx LLC Corporate Summary_x000D_
Table 35. NorthStar Rx LLC Cyclophosphamide Product Offerings_x000D_
Table 36. NorthStar Rx LLC Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)_x000D_
Table 37. GLS Pharma Corporate Summary_x000D_
Table 38. GLS Pharma Cyclophosphamide Product Offerings_x000D_
Table 39. GLS Pharma Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)_x000D_
Table 40. CSC Pharmaceuticals International Corporate Summary_x000D_
Table 41. CSC Pharmaceuticals International Cyclophosphamide Product Offerings_x000D_
Table 42. CSC Pharmaceuticals International Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)_x000D_
Table 43. Cyclophosphamide Production Capacity (Person) of Local Manufacturers in India, 2015-2020_x000D_
Table 44. Cyclophosphamide Production (Person) of Local Manufacturers in India, 2015-2020_x000D_
Table 45. India Cyclophosphamide Production Market Share of Local Manufacturers, 2015-2020_x000D_
Table 46. Cyclophosphamide Production Value (US$, Mn) of Local Manufacturers in India, 2015-2020_x000D_
Table 47. India Cyclophosphamide Production Value Market Share of Local Manufacturers, 2015-2020_x000D_
Table 48. The Percentage of Cyclophosphamide Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 49. The Percentage of Cyclophosphamide Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 50. Dangeguojia Cyclophosphamide Sales (Consumption), Production, Export and Import, 2015-2020_x000D_
Table 51. Raw Materials and Suppliers_x000D_
Table 52. Cyclophosphamide Downstream Clients in India_x000D_
Table 53. Cyclophosphamide Distributors and Sales Agents in India_x000D_
List of Figures_x000D_
Figure 1. Cyclophosphamide Segment by Type_x000D_
Figure 2. Cyclophosphamide Segment by Application_x000D_
Figure 3. Dangeguojia Cyclophosphamide Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. Cyclophosphamide Market Size in India, (US$, Mn) & (Person): 2020 VS 2026_x000D_
Figure 6. India Cyclophosphamide Revenue, 2015-2026 (US$, Mn)_x000D_
Figure 7. Cyclophosphamide Sales in India: 2015-2026 (Person)_x000D_
Figure 8. The Top 3 and 5 Players Market Share by Cyclophosphamide Revenue in 2019_x000D_
Figure 9. By Type - India Cyclophosphamide Incremental Growth, (US$, Mn), 2015-2026_x000D_
Figure 10. By Type - India Cyclophosphamide Market Share, 2015-2020_x000D_
Figure 11. By Type - India Cyclophosphamide Market Share, 2020-2026_x000D_
Figure 12. By Type - India Cyclophosphamide Price (Average Cost/Person), 2015-2026_x000D_
Figure 13. By Application - Cyclophosphamide Revenue in India (US$, Mn), 2020 & 2026_x000D_
Figure 14. By Application - India Cyclophosphamide Market Share, 2015-2020_x000D_
Figure 15. By Application - India Cyclophosphamide Market Share, 2020-2026_x000D_
Figure 16. By Application -India Cyclophosphamide Price (Average Cost/Person), 2015-2026_x000D_
Figure 17. India Cyclophosphamide Production Capacity (Person), 2015-2026_x000D_
Figure 18. India Cyclophosphamide Actual Output (Person), 2015-2026_x000D_
Figure 19. India Cyclophosphamide Production Value (US$, Mn), 2015-2026_x000D_
Figure 20. The Percentage of India Cyclophosphamide Export Destination, 2019_x000D_
Figure 21. The Source of Imports of India Cyclophosphamide, 2019_x000D_
Figure 22. PEST Analysis for India Cyclophosphamide Market in 2020_x000D_
Figure 23. Cyclophosphamide Market Opportunities & Trends in India_x000D_
Figure 24. Cyclophosphamide Market Drivers in India_x000D_
Figure 25. Cyclophosphamide Market Restraints in India_x000D_
Figure 26. Cyclophosphamide Industry Value Chain_x000D_

Kindly Fill The Form Below

Report Title: Cyclophosphamide Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026


Valid Invalid number

Related Report

2021-2025 Vietnam Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Vietnam Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Venezuela Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Venezuela Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Uruguay Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Uruguay Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 United Arab Emirates Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 United Arab Emirates Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Ukraine Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Ukraine Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Turkey Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Turkey Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


SELECT A FORMAT

ADD TO CART BUY NOW